Advanced search
Publication Cover
Bioengineered Volume 13, 2022 - Issue 4
Submit an article Journal homepage
1,727
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Nuclear receptor 4A1 (NR4A1) silencing protects hepatocyte against hypoxia-reperfusion injury in vitro by activating liver kinase B1 (LKB1)/AMP-activated protein kinase (AMPK) signaling

Yu Zhenga Hepatobiliary Pancreatic Surgery Department, Tongde Hospital of Zhejiang Province, Hangzhou, ChinaView further author information
,
Yingying Taob Emergency Intensive Care Unit, Hangzhou Ninth People’s Hospital, Hangzhou, ChinaView further author information
,
Xiaobo Zhana Hepatobiliary Pancreatic Surgery Department, Tongde Hospital of Zhejiang Province, Hangzhou, ChinaView further author information
&
Qi Wua Hepatobiliary Pancreatic Surgery Department, Tongde Hospital of Zhejiang Province, Hangzhou, ChinaCorrespondence[email protected]
View further author information
Pages 8349-8359 | Received 27 Jan 2022, Accepted 10 Mar 2022, Published online: 21 Mar 2022

Related Research Data

Nuclear receptor 4A1 (NR4A1) silencing protects hepatocyte against hypoxia-reperfusion injury in vitro by activating liver kinase B1 (LKB1)/AMP-activated protein kinase (AMPK) signaling
Source: Taylor & Francis

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.